-
1
-
-
73349134695
-
NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide
-
Wick W, Hartmann C, Engel C, et al. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol. 2009;27(35):5874-5880.
-
(2009)
J Clin Oncol.
, vol.27
, Issue.35
, pp. 5874-5880
-
-
Wick, W.1
Hartmann, C.2
Engel, C.3
-
2
-
-
65349121788
-
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
-
Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459-466.
-
(2009)
Lancet Oncol.
, vol.10
, Issue.5
, pp. 459-466
-
-
Stupp, R.1
Hegi, M.E.2
Mason, W.P.3
-
3
-
-
7244253081
-
Nrf2-Keap1 defines a physiologically important stress response mechanism
-
Motohashi H, Yamamoto M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med. 2004;10(11):549-557.
-
(2004)
Trends Mol Med.
, vol.10
, Issue.11
, pp. 549-557
-
-
Motohashi, H.1
Yamamoto, M.2
-
4
-
-
78751703950
-
Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution
-
Taguchi K, Motohashi H, Yamamoto M. Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells. 2011;16(2):123-140.
-
(2011)
Genes Cells.
, vol.16
, Issue.2
, pp. 123-140
-
-
Taguchi, K.1
Motohashi, H.2
Yamamoto, M.3
-
5
-
-
33750885385
-
Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer
-
Singh A, Misra V, Thimmulappa RK, et al. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med. 2006;3(10):e420.
-
(2006)
PLoS Med.
, vol.3
, Issue.10
, pp. e420
-
-
Singh, A.1
Misra, V.2
Thimmulappa, R.K.3
-
6
-
-
51649130168
-
Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy
-
Shibata T, Ohta T, Tong KI, et al. Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc Natl Acad Sci U S A. 2008;105(36):13568-13573.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, Issue.36
, pp. 13568-13573
-
-
Shibata, T.1
Ohta, T.2
Tong, K.I.3
-
7
-
-
53049105119
-
Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer
-
Shibata T, Kokubu A, Gotoh M, et al. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. Gastroenterology. 2008;135(4):1358-1368.
-
(2008)
Gastroenterology
, vol.135
, Issue.4
, pp. 1358-1368
-
-
Shibata, T.1
Kokubu, A.2
Gotoh, M.3
-
8
-
-
76649089973
-
Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth
-
Zhang P, Singh A, Yegnasubramanian S, et al. Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth. Mol Cancer Ther. 2010;9(2):336-346.
-
(2010)
Mol Cancer Ther.
, vol.9
, Issue.2
, pp. 336-346
-
-
Zhang, P.1
Singh, A.2
Yegnasubramanian, S.3
-
9
-
-
79960958309
-
Keap1 mutations and NRF2 pathway activation in epithelial ovarian cancer
-
Konstantinopoulos PA, Spentzos D, Fountzilas E, et al. Keap1 mutations and NRF2 pathway activation in epithelial ovarian cancer. Cancer Res. 2011;71(15):5081-5089.
-
(2011)
Cancer Res.
, vol.71
, Issue.15
, pp. 5081-5089
-
-
Konstantinopoulos, P.A.1
Spentzos, D.2
Fountzilas, E.3
-
10
-
-
77954695549
-
Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features
-
Solis LM, Behrens C, Dong W, et al. Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features. Clin Cancer Res. 2010;16(14):3743-3753.
-
(2010)
Clin Cancer Res.
, vol.16
, Issue.14
, pp. 3743-3753
-
-
Solis, L.M.1
Behrens, C.2
Dong, W.3
-
11
-
-
84862811895
-
Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma
-
Inoue D, Suzuki T, Mitsuishi Y, et al. Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma. Cancer Sci. 2012;103(4):760-766.
-
(2012)
Cancer Sci.
, vol.103
, Issue.4
, pp. 760-766
-
-
Inoue, D.1
Suzuki, T.2
Mitsuishi, Y.3
-
12
-
-
80053439769
-
NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer
-
Shibata T, Kokubu A, Saito S, et al. NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer. Neoplasia. 2011;13(9):864-873.
-
(2011)
Neoplasia.
, vol.13
, Issue.9
, pp. 864-873
-
-
Shibata, T.1
Kokubu, A.2
Saito, S.3
-
13
-
-
77958113395
-
Correlation of Nrf2, HO-1, and MRP3 in gallbladder cancer and their relationships to clinicopathologic features and survival
-
Wang J, Zhang M, Zhang L, et al. Correlation of Nrf2, HO-1, and MRP3 in gallbladder cancer and their relationships to clinicopathologic features and survival. J Surg Res. 2010;164(1):99-105.
-
(2010)
J Surg Res.
, vol.164
, Issue.1
, pp. 99-105
-
-
Wang, J.1
Zhang, M.2
Zhang, L.3
-
14
-
-
84899865579
-
NRF2 immunolocalization in human breast cancer patients as a prognostic factor
-
Onodera Y, Motohashi H, Takagi K, et al. NRF2 immunolocalization in human breast cancer patients as a prognostic factor. Endocr Relat Cancer. 2014;21(2):241-252.
-
(2014)
Endocr Relat Cancer
, vol.21
, Issue.2
, pp. 241-252
-
-
Onodera, Y.1
Motohashi, H.2
Takagi, K.3
-
15
-
-
84879666141
-
ERK and PI3 K signaling cascades induce Nrf2 activation and regulate cell viability partly through Nrf2 in human glioblastoma cells
-
Cong ZX, Wang HD, Wang JW, et al. ERK and PI3 K signaling cascades induce Nrf2 activation and regulate cell viability partly through Nrf2 in human glioblastoma cells. Oncol Rep. 2013;30(2):715-722.
-
(2013)
Oncol Rep.
, vol.30
, Issue.2
, pp. 715-722
-
-
Cong, Z.X.1
Wang, H.D.2
Wang, J.W.3
-
16
-
-
84878187382
-
Knockdown of NF-E2-related factor 2 inhibits the proliferation and growth of U251MG human glioma cells in a mouse xenograft model
-
Ji XJ, Chen SH, Zhu L, et al. Knockdown of NF-E2-related factor 2 inhibits the proliferation and growth of U251MG human glioma cells in a mouse xenograft model. Oncol Rep. 2013;30(1):157-164.
-
(2013)
Oncol Rep.
, vol.30
, Issue.1
, pp. 157-164
-
-
Ji, X.J.1
Chen, S.H.2
Zhu, L.3
-
17
-
-
56749156414
-
Analysis of the IDH1 codon 132 mutation in brain tumors
-
Balss J, Meyer J, Mueller W, et al. Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol. 2008;116(6):597-602.
-
(2008)
Acta Neuropathol
, vol.116
, Issue.6
, pp. 597-602
-
-
Balss, J.1
Meyer, J.2
Mueller, W.3
-
18
-
-
52949127312
-
An integrated genomic analysis of human glioblastoma multiforme
-
Parsons DW, Jones S, Zhang X, et al. An integrated genomic analysis of human glioblastoma multiforme. Science. 2008;321(5897):1807-1812.
-
(2008)
Science
, vol.321
, Issue.5897
, pp. 1807-1812
-
-
Parsons, D.W.1
Jones, S.2
Zhang, X.3
-
19
-
-
70349594347
-
Analysis of IDH1 and IDH2 mutations in Japanese glioma patients
-
Sonoda Y, Kumabe T, Nakamura T, et al. Analysis of IDH1 and IDH2 mutations in Japanese glioma patients. Cancer Sci. 2009;100(10):1996-1998.
-
(2009)
Cancer Sci.
, vol.100
, Issue.10
, pp. 1996-1998
-
-
Sonoda, Y.1
Kumabe, T.2
Nakamura, T.3
-
20
-
-
84886439157
-
Isocitrate dehydrogenase 1 mutant R132H sensitizes glioma cells to BCNU-induced oxidative stress and cell death
-
Mohrenz IV, Antonietti P, Pusch S, et al. Isocitrate dehydrogenase 1 mutant R132H sensitizes glioma cells to BCNU-induced oxidative stress and cell death. Apoptosis. 2013;18(11):1416-1425.
-
(2013)
Apoptosis
, vol.18
, Issue.11
, pp. 1416-1425
-
-
Mohrenz, I.V.1
Antonietti, P.2
Pusch, S.3
-
21
-
-
79952769109
-
Mutant IDH1 confers an in vivo growth in a melanoma cell line with BRAF mutation
-
Shibata T, Kokubu A, Miyamoto M, et al. Mutant IDH1 confers an in vivo growth in a melanoma cell line with BRAF mutation. Am J Pathol. 2011;178(3):1395-1402.
-
(2011)
Am J Pathol.
, vol.178
, Issue.3
, pp. 1395-1402
-
-
Shibata, T.1
Kokubu, A.2
Miyamoto, M.3
-
22
-
-
38349189124
-
Depiction of metabolome changes in histidine-starved Escherichia coli by CE-TOFMS
-
Ohashi Y, Hirayama A, Ishikawa T, et al. Depiction of metabolome changes in histidine-starved Escherichia coli by CE-TOFMS. Mol Biosyst. 2008;4(2):135-147.
-
(2008)
Mol Biosyst.
, vol.4
, Issue.2
, pp. 135-147
-
-
Ohashi, Y.1
Hirayama, A.2
Ishikawa, T.3
-
23
-
-
84858796263
-
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
-
Turcan S, Rohle D, Goenka A, et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature. 2012;483(7390):479-483.
-
(2012)
Nature
, vol.483
, Issue.7390
, pp. 479-483
-
-
Turcan, S.1
Rohle, D.2
Goenka, A.3
-
24
-
-
70249097408
-
Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas
-
Sanson M, Marie Y, Paris S, et al. Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol. 2009;27(25):4150-4154.
-
(2009)
J Clin Oncol.
, vol.27
, Issue.25
, pp. 4150-4154
-
-
Sanson, M.1
Marie, Y.2
Paris, S.3
-
25
-
-
0026755187
-
Regulation of human NAD (P) H: Quinone oxidoreductase gene. Role of AP-1 binding site contained within human antioxidant response element
-
Li Y, Jaiswal AK. Regulation of human NAD (P) H: quinone oxidoreductase gene. Role of AP-1 binding site contained within human antioxidant response element. J Biol Chem. 1992;267(21):15097-15104.
-
(1992)
J Biol Chem.
, vol.267
, Issue.21
, pp. 15097-15104
-
-
Li, Y.1
Jaiswal, A.K.2
-
26
-
-
0030956247
-
Constitutive and betanaphthoflavoneinduced expression of the human gammaglutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response element/TRE sequence
-
Mulcahy RT, Wartman MA, Bailey HH, et al. Constitutive and betanaphthoflavoneinduced expression of the human gammaglutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response element/TRE sequence. J Biol Chem. 1997;272(11):7445-7454.
-
(1997)
J Biol Chem.
, vol.272
, Issue.11
, pp. 7445-7454
-
-
Mulcahy, R.T.1
Wartman, M.A.2
Bailey, H.H.3
-
27
-
-
0036570346
-
Glutamate-cysteine ligase modifier subunit: Mouse Gclm gene structure and regulation by agents that cause oxidative stress
-
Solis WA, Dalton TP, Dieter MZ, et al. Glutamate-cysteine ligase modifier subunit: mouse Gclm gene structure and regulation by agents that cause oxidative stress. Biochem Pharmacol. 2002;63(9):1739-1754.
-
(2002)
Biochem Pharmacol.
, vol.63
, Issue.9
, pp. 1739-1754
-
-
Solis, W.A.1
Dalton, T.P.2
Dieter, M.Z.3
-
28
-
-
72049125350
-
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
-
Dang L, White DW, Gross S, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 2009;462(7274):739-744.
-
(2009)
Nature
, vol.462
, Issue.7274
, pp. 739-744
-
-
Dang, L.1
White, D.W.2
Gross, S.3
-
29
-
-
84862786878
-
Somatic mutations of the KEAP1 gene in common solid cancers
-
Yoo NJ, Kim HR, Kim YR, et al. Somatic mutations of the KEAP1 gene in common solid cancers. Histopathology. 2012;60(6):943-952.
-
(2012)
Histopathology
, vol.60
, Issue.6
, pp. 943-952
-
-
Yoo, N.J.1
Kim, H.R.2
Kim, Y.R.3
-
30
-
-
77950823830
-
Mutations in Keap1 are a potential prognostic factor in resected non-small cell lung cancer
-
Takahashi T, Sonobe M, Menju T, et al. Mutations in Keap1 are a potential prognostic factor in resected non-small cell lung cancer. J Surg Oncol. 2010;101(6):500-506.
-
(2010)
J Surg Oncol.
, vol.101
, Issue.6
, pp. 500-506
-
-
Takahashi, T.1
Sonobe, M.2
Menju, T.3
-
31
-
-
65349150503
-
IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas
-
Watanabe T, Nobusawa S, Kleihues P, et al. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol. 2009;174(4):1149-1153.
-
(2009)
Am J Pathol.
, vol.174
, Issue.4
, pp. 1149-1153
-
-
Watanabe, T.1
Nobusawa, S.2
Kleihues, P.3
-
32
-
-
80052765905
-
Alterations in the RB1 pathway in low-grade diffuse gliomas lacking common genetic alterations
-
Kim YH, Lachuer J, Mittelbronn M, et al. Alterations in the RB1 pathway in low-grade diffuse gliomas lacking common genetic alterations. Brain Pathol. 2011;21(6):645-651.
-
(2011)
Brain Pathol.
, vol.21
, Issue.6
, pp. 645-651
-
-
Kim, Y.H.1
Lachuer, J.2
Mittelbronn, M.3
-
33
-
-
80053215336
-
TET2 promoter methylation in low-grade diffuse gliomas lacking IDH1/2 mutations
-
Kim YH, Pierscianek D, Mittelbronn M, et al. TET2 promoter methylation in low-grade diffuse gliomas lacking IDH1/2 mutations. J Clin Pathol. 2011;64(10):850-852.
-
(2011)
J Clin Pathol.
, vol.64
, Issue.10
, pp. 850-852
-
-
Kim, Y.H.1
Pierscianek, D.2
Mittelbronn, M.3
-
34
-
-
84863764614
-
Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming
-
Mitsuishi Y, Taguchi K, Kawatani Y, et al. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell. 2012;22(1):66-79.
-
(2012)
Cancer Cell.
, vol.22
, Issue.1
, pp. 66-79
-
-
Mitsuishi, Y.1
Taguchi, K.2
Kawatani, Y.3
|